-transparent.png){kind=logo}
Monoclonal antibody BA-1 binds to B lymphocytes, to cells from most cases of non-T acute lymphoblastic leukemia (ALL), and weakly to neutrophils. To determine whether BA-1 also reacts with hematopoietic progenitor cells (HPC), we studied the effect of removal of BA-1+ cells from human bone marrow on the proliferation in vitro of the trilineage precursor cell CFU-GEMM, and on the committed progenitor cells of granulopoiesis (CFU-C) and erythropoiesis (BFU-E/CFU-E). Complement-mediated cytotoxicity using BA-1 at concentrations far beyond those required to lyse BA-1+ bone marrow cells and ALL cells did not result in inhibition of colony formation in any of the assays. A rosette separation method, using ox red blood cells coated with BA-1, resulted in enrichment of HPC in the BA-1-depleted interface, whereas very few HPC were found in the BA-1-enriched pellet. Both methods indicate that BA-1 does not bind to HPC, although binding of the antibody to the lymphohematopoietic stem cell cannot be excluded yet. The high cytotoxic capacity of the IgM antibody BA-1, and the lack of reactivity with HPC, make the antibody particularly suitable for use in autologous bone marrow transplantation for patients with ALL.
J Jansen, and
R C Ash, and
E D Zanjani, and
T W LeBien, and
J H Kersey
May 2007,
Rheumatology (Oxford, England),
J Jansen, and
R C Ash, and
E D Zanjani, and
T W LeBien, and
J H Kersey
January 1981,
Journal of immunology (Baltimore, Md. : 1950),
J Jansen, and
R C Ash, and
E D Zanjani, and
T W LeBien, and
J H Kersey
April 1997,
Journal of hematotherapy,
J Jansen, and
R C Ash, and
E D Zanjani, and
T W LeBien, and
J H Kersey
January 1985,
Progress in clinical and biological research,
J Jansen, and
R C Ash, and
E D Zanjani, and
T W LeBien, and
J H Kersey
January 1992,
Microbiology and immunology,
J Jansen, and
R C Ash, and
E D Zanjani, and
T W LeBien, and
J H Kersey
August 2013,
Oncogene,
J Jansen, and
R C Ash, and
E D Zanjani, and
T W LeBien, and
J H Kersey
February 1994,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
J Jansen, and
R C Ash, and
E D Zanjani, and
T W LeBien, and
J H Kersey
March 2001,
The Journal of clinical investigation,
J Jansen, and
R C Ash, and
E D Zanjani, and
T W LeBien, and
J H Kersey
February 1996,
Blood,
J Jansen, and
R C Ash, and
E D Zanjani, and
T W LeBien, and
J H Kersey
January 1997,
Stem cells (Dayton, Ohio),
